LON:FUM

Futura Medical - FUM Share Forecast, Price & News

GBX 35.60

+0.80 (+2.30%)

(As of 08/8/2022 04:26 AM ET)

Add

Compare

Today's Range: 34.55
▼
36.20
50-Day Range: 28.23
▼
36.20
52-Week Range: 24
▼
44.10

Volume: 19,011 shs
Average Volume: 365,785 shs
Market Capitalization: £102.28 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: GBX 102

Futura Medical MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 186.5% Upside
GBX 102 Price Target
Short Interest: N/A
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.50 out of 5 stars

3.5

Analyst's Opinion

Consensus Rating
Futura Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of GBX 102, Futura Medical has a forecasted upside of 186.5% from its current price of GBX 35.60.
Amount of Analyst Coverage
Futura Medical has received no research coverage in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for FUM.

0.0

Dividend Strength

Dividend Yield
Futura Medical does not currently pay a dividend.
Dividend Growth
Futura Medical does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for FUM.

0.0

News and Social Media Coverage

MarketBeat Follows
Only 1 people have added Futura Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

N/A

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Futura Medical insiders have not sold or bought any company stock.

0.0

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Futura Medical is -19.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Futura Medical is -19.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Futura Medical has a P/B Ratio of 10.47. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Futura Medical (LON:FUM) Stock

Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. The company was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

Futura Medical Price Performance

LON:FUM traded down GBX 1.40 ($0.02) on Friday, reaching GBX 34.80 ($0.43). The stock had a trading volume of 331,541 shares, compared to its average volume of 368,112. The company has a market cap of £99.98 million and a price-to-earnings ratio of -19.33. The firm's fifty day moving average is GBX 30.36 and its two-hundred day moving average is GBX 29.29. Futura Medical has a 12-month low of GBX 24 ($0.29) and a 12-month high of GBX 44.10 ($0.54).

Receive FUM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Futura Medical and its competitors with MarketBeat's FREE daily newsletter.

FUM Stock News Headlines

June 28, 2022 | proactiveinvestors.com

Futura Medical set for another period of key news flow

June 28, 2022 | proactiveinvestors.com

Futura Medical on track to disclose the results of FM71 study in early September

June 20, 2022 | uk.finance.yahoo.com

Will the Futura Medical share price run continue?

June 13, 2022 | finance.yahoo.com

Here's Why We're Not Too Worried About Futura Medical's (LON:FUM) Cash Burn Situation

May 23, 2022 | proactiveinvestors.com.au

Judges Scientific makes earnings-enhancing acquisition

May 23, 2022 | proactiveinvestors.com

Futura Medical upgraded after Cooper Health deal

May 23, 2022 | proactiveinvestors.com.au

Proactive news headlines: Quantum Blockchain, Futura Medical, Condor Gold, and more

May 23, 2022 | proactiveinvestors.com.au

Futura Medical licenses ED treatment in Europe to Cooper

April 28, 2022 | finance.yahoo.com

What Is The Ownership Structure Like For Futura Medical plc (LON:FUM)?

March 23, 2022 | proactiveinvestors.com.au

Arecor Therapeutics boosted by grant of US insulin patents

March 23, 2022 | proactiveinvestors.com.au

Futura Medical agrees South Korean licensing deal for erectile dysfunction gel

March 23, 2022 | marketwatch.com

Futura Medical Licenses Erectile-Dysfunction Treatment in South Korea

March 23, 2022 | proactiveinvestors.com

Futura Medical signs South Korean licensing deal for erectile dysfunction gel MED3000

September 30, 2021 | finance.yahoo.com

What Kind Of Shareholders Hold The Majority In Futura Medical plc's (LON:FUM) Shares?

August 31, 2021 | proactiveinvestors.com

Futura Medical PLC - Futura Medical Announces Collaboration of MED3000

August 31, 2021 | finance.yahoo.com

M8 Pharmaceuticals Announces License of Exclusive rights MED3000 from Futura Medical for Latin America

August 20, 2021 | fool.co.uk

Futura Medical (LSE:FUM)

April 3, 2021 | finance.yahoo.com

How Much Of Futura Medical plc (LON:FUM) Do Insiders Own?

March 22, 2021 | fool.co.uk

What I’d do after the Futura Medical share price rose 65% today

March 19, 2021 | fool.co.uk

Penny share in focus: why did the Futura Medical share price soar 125%+ today?

March 19, 2021 | lse.co.uk

Futura Medical shares jump as erectile dysfunction drug nears approval

December 7, 2020 | marketwatch.com

Erectile Dysfunction Drugs Market Projected to Grow at a CAGR of 5.0% During 2017- 2027|Pfizer, Inc., Dong-A ST Co., Ltd, Eli Lilly and Company

October 9, 2020 | au.finance.yahoo.com

Futura Medical PLC Registered S (GYX.SG)

June 24, 2020 | www.lse.co.uk

Futura makes good progress with topical erectile dysfunction treatment

June 10, 2020 | uk.finance.yahoo.com

What does the future hold for the Futura Medical share price?

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive FUM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Futura Medical and its competitors with MarketBeat's FREE daily newsletter.

FUM Company Calendar

Last Earnings: 9/16/2020
Today: 8/07/2022
Next Earnings (Estimated): 9/27/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Drug Manufacturers - Major
Sub-Industry: N/A
Sector: Medical
Current Symbol: LON:FUM
CUSIP: N/A
CIK: N/A
Web: www.futuramedical.com
Phone: +44-1483-685670
Fax: N/A
Employees: 13
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: GBX 102
High Stock Price Forecast: GBX 102
Low Stock Price Forecast: GBX 102
Forecasted Upside/Downside: +186.5%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 5.47
Quick Ratio: 5.43

Sales & Book Value

Annual Sales: £31,778.00
Price / Sales: 3,218.51
Cash Flow: GBX 3.56 per share
Price / Cash Flow: 10.00
Book Value: GBX 3.40 per share
Price / Book: 10.47

Miscellaneous

Outstanding Shares: 287,297,000
Free Float: N/A
Market Cap: £102.28 million
Optionable: Not Optionable
Beta: N/A

Key Executives

Mr. James Henry Barder (Age 62)
CEO & Exec. Director
Comp: $356.86k
Ms. Angela Hildreth
COO, Fin. Director, Company Sec. & Exec. Director
Mr. Kenneth William James (Age 69)
Head of R&D & Exec. Director
Comp: $267.27k
Dr. William Duncan Potter (Age 74)
Chief Scientific Officer & Adviser to the Board
Graham Smith
Head of Alliance Partnerships & Supply
Kevin Langridge
Head of Quality

Key Competitors

View All Competitors

FUM Stock - Frequently Asked Questions

Should I buy or sell Futura Medical stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Futura Medical in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" Futura Medical stock.
View analyst ratings for Futura Medical or view top-rated stocks.
What is Futura Medical's stock price forecast for 2022?: 1 equities research analysts have issued twelve-month price targets for Futura Medical's shares. Their FUM stock forecasts range from GBX 102 to GBX 102. On average, they expect Futura Medical's stock price to reach GBX 102 in the next year. This suggests a possible upside of 193.1% from the stock's current price.
View analysts' price targets for Futura Medical or view top-rated stocks among Wall Street analysts.
How has Futura Medical's stock price performed in 2022?: Futura Medical's stock was trading at GBX 39.30 at the beginning of the year. Since then, FUM shares have decreased by 11.5% and is now trading at GBX 34.80.
View the best growth stocks for 2022 here.
When is Futura Medical's next earnings date?: Futura Medical is scheduled to release its next quarterly earnings announcement on Tuesday, September 27th 2022.
View our earnings forecast for Futura Medical.
How were Futura Medical's earnings last quarter?: Futura Medical plc (LON:FUM) posted its quarterly earnings results on Wednesday, September, 16th. The company reported ($0.44) earnings per share (EPS) for the quarter.

What other stocks do shareholders of Futura Medical own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Futura Medical investors own include Indivior (INDV), Tullow Oil (TLW), Bigblu Broadband (BBB), Directa Plus (DCTA), Genel Energy (GENL), Lakehouse (LAKE), Petrel Resources (PET), People's Operator (TPOP), CityFibre Infrastructure (CITY) and Paysafe Group (PAYS).
What is Futura Medical's stock symbol?: Futura Medical trades on the London Stock Exchange (LON) under the ticker symbol "FUM."
How do I buy shares of Futura Medical?: Shares of FUM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What is Futura Medical's stock price today?: One share of FUM stock can currently be purchased for approximately GBX 34.80.
How much money does Futura Medical make?: Futura Medical (LON:FUM) has a market capitalization of £99.98 million and generates £31,778.00 in revenue each year.
How many employees does Futura Medical have?: Futura Medical employs 13 workers across the globe.
How can I contact Futura Medical?: Futura Medical's mailing address is 40 Surrey Technology Centre, Occam Road, GUILDFORD, GU2 7YG, United Kingdom. The official website for Futura Medical is www.futuramedical.com. The company can be reached via phone at +44-1483-685670.

This page (LON:FUM) was last updated on 8/8/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Futura Medical - FUM Share Forecast, Price & News

Futura Medical MarketRank™ Forecast

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Futura Medical (LON:FUM) Stock

Futura Medical Price Performance

FUM Stock News Headlines

FUM Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

FUM Stock - Frequently Asked Questions

Should I buy or sell Futura Medical stock right now?

What is Futura Medical's stock price forecast for 2022?

How has Futura Medical's stock price performed in 2022?

When is Futura Medical's next earnings date?

How were Futura Medical's earnings last quarter?

What other stocks do shareholders of Futura Medical own?

What is Futura Medical's stock symbol?

How do I buy shares of Futura Medical?

What is Futura Medical's stock price today?

How much money does Futura Medical make?

How many employees does Futura Medical have?

How can I contact Futura Medical?

MarketBeat Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

Overall MarketRank^™